Key result
Analysis of 2,237 respiratory samples using a 14-virus multiplex nucleic acid amplification test yielded a 35.2% positivity rate, with human rhinovirus being the most prevalent.
Why the study?
What is the etiology and prevalence of respiratory viral infections detected by a 14-virus multiplex panel in hospitalized children and adults?
Observational (n=2,237)
No
What is the etiology and prevalence of respiratory viral infections detected by a 14-virus multiplex panel in hospitalized children and adults?
A 14-virus multiplex panel identified a 35.2% positivity rate for respiratory viruses in hospitalized patients, highlighting the high prevalence of human rhinovirus and viral coinfections.
Informs viral etiology in hospitalized respiratory cases; leaves open impact on clinical decisions and outcomes.
OBJECTIVES: To investigate the etiology of viral respiratory tract infections mainly in hospitalized children and adults over a 12-month consecutive period after implementation of a 14-virus multiplex nucleic acid amplification test. METHODS: From January 2014 to January 2015, a total of 2,237 respiratory samples were analyzed with the US Food and Drug Administration-cleared eSensor Respiratory Viral Panel (GenMark Diagnostics, Carlsbad, CA). RESULTS: Of the 2,237 specimens tested, 788 specimens were positive for at least one virus, giving a positivity rate of 35.2%, and because of viral codetection, a total of 862 viral targets were identified. The age groups with the highest positivity rates were the 0- to 1-year (73.5%) and 2- to 6-year (78.4%) age groups. The overall viral codetection rate was 9.1%. Human rhinovirus (HRV) was the most prevalent respiratory virus found in children and adults. The peak of HRV seen in September 2014 represented a combination of HRV and enterovirus D68, 2014 epidemic respiratory infections. CONCLUSION: The ability to detect a wider range of respiratory viruses gave us a better understanding of the etiology of respiratory infections in our population, particularly for HRV and enhanced our ability to detect viral coinfection.
No takes yet. Share an insight, caveat, or question.
Arbefeville et al. (2016) conducted an observational in Viral respiratory tract infections (n=2,237). 14-virus multiplex nucleic acid amplification test was evaluated on Positivity for at least one virus. Analysis of 2,237 respiratory samples using a 14-virus multiplex nucleic acid amplification test yielded a 35.2% positivity rate, with human rhinovirus being the most prevalent.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: